Junin (Argentine Hemorrhagic Fever)

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2009, Pages 537-550

  McKee, Kelly T ^a   Enria, Delia A ^b   Barrera Oro, Julio G ^c  

^a IQVIA   (United States)

^b Instituto Nacional de Enfermedades Virales Humanas Dr Julio I Maiztegui   (Argentina)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871536154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00029-9     Document Type: Chapter

References (121)

1. Agnese, G. Historia de una enfermedad, imaginario y espacio rural: La fiebre hemorrágica argentina-1943-1963. Tesis para optar al grado de Licenciatura en Historia. 5.2. Experiencias en el Hospital Neuropsiquiátrico. Pontificia Universidad Católica Argentina. Facultad de derecho y Ciencias Sociales. Argentina: Instituto de Historia. Rosario, 1999.
2. Alibek K. Biohazard 1999, Random House, New York, NY.
3. Alvarez Ambrosetti, E., Cintora, F.A., Locisero, R., Magnoni, C., Milani, H. and Vaccarezza, R., Fiebre hemorragica epidemica; observaciones clinicas. Dia Medico 1959; 31:232-235.
4. Ambrosio A.M., del Carmen Saavedra M., Riera L.M., Fassio R.M. La producción nacional de vacuna a virus Junin vivo atenuado (Candid {music sharp sign}1) anti-fiebre hemorrágica argentina. Acta Bioquím. Clín. Latinoam. 2006, 40:5-17.
5. Arribalzaga R.A. Una nueva enfermedad epidémica a germen desconocido: Hipertérmia, nefrotóxica, leucopénica y enantemática. Día Méd. 1955, 27:1204-1210.
6. Auperin D.D., Esposito J.J., Lange J.V., Bauer S.P., Knight J., Sasso D.R., Mccormick J.B. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res. 1988, 9:233-248.
7. Barrera Oro, J.G. and Eddy, G.A. Characteristics of candidate live attenuated Junin virus vaccine. IV International Conference on Comparative Virology. Banff, Alberta, Canada. Abstract S4-S10, 1982.
8. Barrera Oro J.G., Girola R.A., Gutman Frugone L. Immunological studies with the Junin virus. II. Acquired immunity in guinea pigs with a formol-inactivated virus. Medicina (B. Aires) 1967, 27:279-282.
9. Barrera Oro, J.G., Lupton, H.W., Jahrling, P.B., Meegan, J., Kenyon, R.H. and Peters, C.J. Cross protection against Machupo virus with Candid {music sharp sign}1 live-attenuated Junin virus vaccine. I. The postvaccination prechallenge immune response. Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region. Mar del Plata, Argentina. Abstract P.E.1, 1988.
10. Barrera Oro, J., Macdonald, C., Kenyon, R.H., Meegan, J.M., Cole, F. Jr., Lupton, H.W., and Peters, C.J. Virus isolation and immune response in humans inoculated with a live-attenuated Junin virus (JV) vaccine. VII International Congress of Virology. Edmonton, Alberta, Canada. Abstract R3.45, 1987.
11. Barrera Oro J.G., McKee K.T. Toward a vaccine against Argentine hemorrhagic fever. Bull. Pan Am. Health Organ. 1991, 25:118-126.
12. Barrera Oro, J.G., McKee Jr., K.T., Kuehne, A.I., Moe, J.B., Green, D.E., Cole, F.E. and Lupton, H.W. Preclinical trials of a live, attenuated Junin virus vaccine in rhesus macaques. Institut Pasteur Symposium on Vaccines and Vaccinations. Paris, France. Abstract P28, 1985.
13. Bowen M.D., Peters C.J., Nichol S.T. The phylogeny of New World (Tacaribe complex) arenaviruses. Virology 1996, 219:285-290.
14. Bredenbeek P.J., Molenkamp R., Spaan W.J., Deubel V., Marianneau P., Salvato M.S., Moshkoff D., Zapata J., Tikhonov I., Patterson J., Carrion R., Ticer A., Brasky K., Lukashevich I.S. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology 2006, 345:299-304.
15. Briggiler A.M., Enria D.A., Feuillade M.R., Maiztegui J.I. Contagio interhumano e infección inaparente por virus Junin en matrimonios del área endémica de fiebre hemorrágica Argentina. Medicina (B. Aires) 1987, 47:565.
16. Briggiler A.M., Levis S., Enria D.A., Maiztegui J.I. Argentine hemorrhagic fever in pregnant women. Medicina (B. Aires) 1990, 50:443.
17. Buchmeier M.J., De La Torre J.-C., Peters C.J. Arenaviridae: the viruses and their replication. Field's Virology 2006, Lippincott, Williams, and Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
18. Carballal G., Videla C., Dulout F., Cossio P.M., Acuna A.M., Bianchi N.O. Experimental infection of Akodon molinae (Rodentia, Cricetidae) with Junin virus. J. Med. Virol. 1986, 19:47-54.
19. Carballal G., Videla C., Oubina J.R., Frigerio M.J. Inactivated Junin virus antigens. Medicina (B. Aires) 1985, 45:153-158.
20. Casals J. Serological studies on Junin and Tacaribe viruses. Am. J. Trop. Med. Hyg. 1965, 14:794-796.
21. Notice to readers update: management of patients with suspected viral hemorrhagic fever-United States. MMWR Morb. Mortal. Wkly. Rep. 1995, 44:475-479. Centers for Disease Control and Prevention.
22. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Morb. Mortal. Wkly. Rep. 2000, 49:1-14. Centers for Disease Control and Prevention.
23. Clegg J.C., Lloyd G. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet 1987, 2:186-188.
24. Coto C.E., Damonte E.B., Catello M.A., Weissenbacher M.C. Protection of guinea pigs inoculated with Tacaribe virus against lethal doses of Junin virus. J. Infect. Dis. 1980, 141:389-393.
25. Cresta B., Padula P., de Martinez Segovia M. Biological properties of Junin virus proteins. I. Identification of the immunogenic glycoprotein. Intervirology 1980, 13:284-288.
26. Cummins D., Molinas F.C., Lerer G., Maiztegui J.I., Faint R., Machin S.J. A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 1990, 42:470-475.
27. D'aiutolo A.C., Lampuri J.S., Coto C.E. Reactivacion del virus Junin inactivado por la luz ultravioleta. Medicina (B. Aires) 1979, 39:801.
28. Damonte E.B., Calello M.A., Coto C.E., Weissenbacher M.C. Immunization of guinea pigs against Argentinian hemorrhagic fever with Tacaribe virus replicated in human diploid cells. Medicina (B. Aires) 1981, 41:467-470.
29. de Bracco M.M., Rimoldi M.T., Cossio P.M., Rabinovich A., Maiztegui J.I., Carballal G., Arana R.M. Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. N. Engl. J. Med. 1978, 299:216-221.
30. de Guerrero L.B., Boxaca M., Weissenbacher M., Frigerio M.J. Experimental infection of the guinea pig with Junin virus. Clinical picture, dissemination, and elimination of the virus. Medicina (B. Aires) 1977, 37:271-278.
31. De Guerrero L.B., Weissenbacher M.C., Parodi A.S. Immunization against Argentinian hemorrhagic fever using an attenuated strain of Junin virus. I. Modified strain of Junin virus. Immunization of guinea pigs. Medicina (B. Aires) 1969, 29:1-5.
32. de Martinez Segovia Z.M., Arguelles G., Tokman A. Antigenic capacity of Junin virus inactivated by photodynamic oxidation. Medicina (B. Aires) 1980, 40:156-160.
33. del Carmen Saavedra M., Sottosanti J.M., Riera L., Ambrosio A.M. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection. J. Med. Virol. 2003, 69:447-450.
34. Eddy G.A., Barrera Oro J.G. Discussion general. Medicina (B. Aires) 1977, 37(Suppl. 3):257-259.
35. Enria D., Franco S.G., Ambrosio A., Vallejos K., Levis S., Maiztegui J.I. Current status of the treatment of Argentine hemorrhagic fever. Med. Microbiol. Immunol. 1986, 175:173-176.
36. Enria D.A., Barrera Oro J.G. Junin virus vaccines. Curr. Top. Microbiol. Immunol. 2002, 263:239-261.
37. Enria D.A., Briggiler A.M., Fernandez N.J., Levis S.C., Maiztegui J.I. Importance of dose of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma. Lancet 1984, 2:255-256.
38. Enria, D.A., Briggiler, A.M., Feuillade, M.R., Ambrosio, A.M., Crivelli, E. y el grupo de estudio de la vacuna contra la Fiebre Hemorragica Argentina. Estudio clínico puente, en fase III, en voluntarios humanos sanos, de entre 15 y 65 años de edad, de ambos géneros, a riesgo de adquirir Fiebre Hemorrágica Argentina, aleatorio, a doble ciego, para evaluar la comparabilidad entre la vacuna Candid {music sharp sign}1 producida en la Argentina y la producida en los Estados Unidos. Medicina (B. Aires) (in press).
39. Enria D.A., Feuillade M.R., Levis S.C., Briggiler A.M., Ambrosio A.M., Saavedra M.C., Becker J.L., Riera L., Calderon G., Pini N., Sottosanti J., Aviles G., Grarcia J., Sabattini M. Impact of vaccination of a high risk population for Argentine hemorrhagic fever with a live attenuated Junin virus vaccine. Factors in the Emergence and Control of Rodent-Borne Viral Diseases 1999, Elsevier SAS, Paris, France. J.F. Saluzzo, B. Dodet (Eds.).
40. Fisher-Hoch S.P., Mccormick J.B., Auperin D., Brown B.G., Castor M., Perez G., Ruo S., Conaty A., Brammer L., Bauer S. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:317-321.
41. Garcia J.B., Morzunov S.P., Levis S., Rowe J., Calderon G., Enria D., Sabattini M., Buchmeier M.J., Bowen M.D., St Jeor S.C. Genetic diversity of the Junin virus in Argentina: geographic and temporal patterns. Virology 2000, 272:127-136.
42. Giacalone M.J., Zapata J.C., Berkley N.L., Sabbadini R.A., Chu Y.L., Salvato M.S., Mcguire K.L. Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus. Vaccine 2007, 25:2279-2287.
43. Gomez R.M., Pozner R.G., Lazzari M.A., D'atri L.P., Negrotto S., Chudzinski-Tavassi A.M., Berria M.I., Schattner M. Endothelial cell function alteration after Junin virus infection. Thromb. Haemost. 2003, 90:326-333.
44. Goñi S.E., Iserte J.A., Ambrosio A.M., Romanowski V., Ghiringhelli P.D., Lozano M.E. Genomic features of attenuated Junin virus vaccine strain candidate. Virus Genes 2006, 32:37-41.
45. Gonzales P.H., Laguens R.P., Frigerio M.J., Calello M.A., Weissenbacher M.C. Junin virus infection of Callithrix jacchus: pathologic features. Am. J. Trop. Med. Hyg. 1983, 32:417-423.
46. Gonzalez P.H., Cossio P.M., Arana R., Maiztegui J.I., Laguens R.P. Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features. Arch. Pathol. Lab. Med. 1980, 104:250-254.
47. Green D.E., Mahlandt B.G., McKee K.T.J. Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology. J. Med. Virol. 1987, 22:113-133.
48. Guerrero L.B., Boxaca M.C., Weissenbacher M.C., Frigerio M.J. Infeccion experimental del cobayo con virus Junin. Cuadro clínico, diseminación y eliminación del virus. Medicina (B. Aires) 1977, 37:271-278.
49. Harrison L.H., Halsey N.A., McKee K.T.J., Peters C.J., Barrera Oro J.G., Briggiler A.M., Feuillade M.R., Maiztegui J.I. Clinical case definitions for Argentine hemorrhagic fever. Clin. Infect. Dis. 1999, 28:1091-1094.
50. Heller M.V., Marta R.F., Sturk A., Maiztegui J.I., Hack C.E., Cate J.W., Molinas F.C. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb. Haemost. 1995, 73:368-373.
51. Heller M.V., Saavedra M.C., Falcoff R., Maiztegui J.I., Molinas F.C. Increased levels of tumor necrosis factor alpha in Argentine hemorrhagic fever. J. Infect. Dis. 1992, 166:1203-1204.
52. Jahrling, P.B., Trotter, R.W., Barrera Oro, J.G., Lupton, H.W., Cosgriff, T.M., Lewis, R.W., Parrish, D.B., Smith, S.B. and Peters, C.J. Cross-protection against Machupo virus with Candid {music sharp sign}1 Junin virus vaccine: III. Post-challenge clinical findings. Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region. Mar del Plata, Argentina. Abstract P.E.3, 1988.
53. Kenyon R.H., Condie R.M., Jahrling P.B., Peters C.J. Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. Microb. Pathog. 1990, 9:219-226.
54. Kenyon, R.H., McKee, K., Barrera Oro, J., Ragland, D., Crabbs, C. and Higgins, Y. Protective efficacies in rhesus monkeys of Candid 1 strain Junin virus (JV) and Tacaribe virus against aerosol challenge with virulent JV. 38th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Honolulu, Hawaii. Abstract 136, 1989.
55. Kenyon R.H., McKee K.T.J., Maiztegui J.I., Green D.E., Peters C.J. Heterogeneity of Junin virus strains. Med. Microbiol. Immunol. 1986, 175:169-172.
56. Kenyon R.H., Peters C.J. Actions of complement on Junin virus. Rev. Infect. Dis. 1989, 11(Suppl. 4):S771-S776.
57. Kunz S., Borrow P., Oldstone M.B. Receptor structure, binding, and cell entry of arenaviruses. Curr. Top. Microbiol. Immunol. 2002, 262:111-137.
58. Lang J., Wood S.C. Development of orphan vaccines: an industry perspective. Emerg. Infect. Dis. 1999, 5:749-756.
59. Levis S.C., Saavedra M.C., Ceccoli C., Falcoff E., Feuillade M.R., Enria D.A., Maiztegui J.I., Falcoff R. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 1984, 149:428-433.
60. Levis S.C., Saavedra M.C., Ceccoli C., Feuillade M.R., Enria D.A., Maiztegui J.I., Falcoff R. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 1985, 5:383-389.
61. Lopez N., Scolaro L., Rossi C., Jacamo R., Candurra N., Pujol C., Damonte E.B., Franze-Fernandez M.T. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs. J. Gen. Virol. 2000, 81:1273-1281.
62. Lupton, H.W., Jahrling, P.B., Barrera Oro, J.G. and Peters, C.J. Cross-protection against Machupo virus with Candid {music sharp sign}1 live-attenuated Junin virus vaccine: II. Post-challenge virological and immunological findings. Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region. Mar del Plata, Argentina. Abstract P.E.2, 1988.
63. MacDonald, C., McKee, K., Meegan, J., Kenyon, R., Parrish, D., Maiztegui, J., Lupton, H., Peters, C. and Barrera Oro, J. Initial evaluation in humans of a live-attenuated vaccine against Argentine hemorrhagic fever. XVI Army Science Conference. Hampton, VA, 1988.
64. MacDonald, C., McKee, K., Peters, C., Feinsod, F., Cosgriff, T. and Barrera Oro, J. Initial clinical assessment of humans inoculated with a live-attenuated Junin virus (JV) vaccine. VII International Congress of Virology. Edmonton, Alberta, Canada. Abstract R3.27, 1987.
65. Maiztegui J.I. Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull. World Health Organ. 1975; 52, 567-575.
66. Maiztegui J., Levis S., Enria D., Feuillade M.R., Cavanagh P., Briggiler A., Conti O., Vallejos D., Tiano E., Jaitovich I., Gamboa G., Becker J.L., Saavedra C., Ambrosio A., McKee K.T., Barrera Oro J. Inocuidad e inmunogenicidad en seres humanos de la cepa Candid 1 de virus Junin. Medicina (B. Aires) 1988, 6:660.
67. Maiztegui J.I., Fernandez N.J., De Damilano A.J. Efficacy of immune plasma treatment of Argentine hemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979, 2:1216-1217.
68. Maiztegui J.I., Feuillade M.R., Briggiler A.M. Progressive extension of the endemic area and changing incidence of AHF. Med. Microbiol. Immunol. 1986, 175:149-152.
69. Maiztegui, J.I. and McKee, K.T.J. Inoculation of human volunteers with a vaccine against Argentine hemorrhagic fever. VI International Conference on Comparative and Applied Virology. Banff, Alberta, Canada. Abstract S4, 1989.
70. Maiztegui J.I., McKee K.T.J., Barrera Oro J.G., Harrison L.H., Gibbs P.H., Feuillade M.R., Enria D.A., Briggiler A.M., Levis S.C., Ambrosio A.M., Halsey N.A., Peters C.J., Group A.T.A.S. Protective efficacy of a live-attenuated vaccine against Argentine hemorrhagic fever. J. Infect. Dis. 1998, 177:277-283.
71. Maiztegui J.I., Sabattini M.S. Extensión progresiva del área endémica de fiebre hemorrágica argentina. Medicina (B. Aires) 1977, 37(Suppl. 3):162-166.
72. Marta R.F., Enria D., Molinas F.C. Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever. Am. J. Hematol. 2000, 64:1-6.
73. Marta R.F., Montero V.S., Hack C.E., Sturk A., Maiztegui J.I., Molinas F.C. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 1999, 60:85-89.
74. McKee K.T.J., Barrera Oro J.G., Kuehne A.I., Spisso J.A., Mahlandt B.G. Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques. Intervirology 1992, 34:154-163.
75. McKee K.T.J., Mahlandt B.G., Maiztegui J.I., Eddy G.A., Peters C.J. Experimental Argentine hemorrhagic fever in rhesus macaques: virus strain-dependent clinical response. J. Infect. Dis. 1985, 45:218-221.
76. McKee K.T.J., Mahlandt B.G., Maiztegui J.I., Green D.E., Peters C.J. Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 1987, 22:99-111.
77. Mettler N.E. Argentine hemorrhagic fever: current knowledge. PAHO Scientific Publication 183 1969, Pan American Health Organization, Washington DC.
78. Mettler N.E., Casals J., Shope R.E. Study of the antigenic relationships between Junin virus, the etiologic agent of Argentinian hemorrhagic fever, and other arthropod-borne viruses. Am. J. Trop. Med. Hyg. 1963, 12:647-652.
79. Meyer B.J., De La Torre J.C., Southern P.J. Arenaviruses: genomic RNAs, transcription, and replication. Curr. Top. Microbiol. Immunol. 2002, 262:139-157.
80. Mills J.N., Childs J.E. Ecologic studies of rodent reservoirs: their relevance for human health. Emerg. Infect. Dis. 1998, 4:529-537.
81. Mills J.N., Ellis B.A., McKee K.T.J., Calderon G.E., Maiztegui J.I., Nelson G.O., Ksiazek T.G., Peters C.J., Childs J.E. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 1992, 47:749-763.
82. Mills J.N., Ellis B.A., McKee K.T.J., Ksiazek T.G., Barrera Oro J.G., Maiztegui J.I., Calderon G.E., Peters C.J., Childs J.E. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am. J. Trop. Med. Hyg. 1991, 44:589-597.
83. Mills J.N., McKee K.T.J. South American hemorrhagic fevers. Hunter's Tropical Medicine and Emerging Infectious Diseases 2000, W.B. Saunders, Co., Philadelphia, PA. 8th ed. G.T. Strickland (Ed.).
84. Morrison H.G., Bauer S.P., Lange J.V., Esposito J.J., Mccormick J.B., Auperin D.D. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 1989, 171:179-188.
85. Oubina J.R., Carballal G., Videla C.M., Cossio P.M. The guinea pig model for Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 1984, 33:1251-1257.
86. Parodi A.S., Coto C.E. Immunization of guinea pigs against the Junin virus by inoculation with Tacaribe virus. Medicina (B. Aires) 1964, 24:151-153.
87. Parodi A.S., De Guerrero L.B., Weissenbacher M. Fiebre hemorrágica argentina: vacunación con virus Junin inactivado. Cienc. Investigación 1965, 21:132-133.
88. Parodi A.S., Greenway D., Rugiero H.R., Rivero E., Frigerio M.J., Mettler N., Garzon F., Boxaca M., Guerrero L., Nota R. Sobre la etiología del brote epidémico en Junín. Día Méd. 1958, 30:2300-2302.
89. Peters C.J., Jahrling P.B., Liu C.T., Kenyon R.H., McKee K.T.J., Barrera Oro J.G. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 1987, 134:5-68.
90. Peters C.J., Shelokov A. Viral hemorrhagic fever. Curr. Ther. Infect. Dis. 1990, 3:355-360.
91. Pirosky I., Zuccarini J., Molinelli E.A., Di Pietro A., Barrera Oro J.G., Martini P., Copello A.R. Virosis hemorrágica del noroeste bonaerense (endemoepidémica, febril, enantémática y leucopénica) 1959, Ministerio de Asistencia Social y Salud Pública, Instituto Nacional de Microbiología, Buenos Aires.
92. Pirosky I., Zuccarini J., Montinelli E.A., Di Pietro A., Martini P., Ferreyra B., Gutman Frugone L.F., Vazquez T. Virosis hemorrágica del noroeste bonaerense. Endemoepidémica, febril, enantemática y leucopénica. I. La primera inoculación experimental al hombre. Orientación Méd. 1959, 8:144-148.
93. Pushko P., Geisbert J., Parker M., Jahrling P., Smith J. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J. Virol. 2001, 75:11677-11685.
94. Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D., Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M., Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 2007, 446:92-96.
95. Rico-Hesse R. Vaccines for emergent American arenaviruses. Factors in the emergence and control of rodent-borne viral diseases 1999, Elsevier SAS, Paris, France. J.B. Saluzzo, B. Dodet (Eds.).
96. Rugiero H.A., Magnoni C., et al. Immunización contra la fiebre hemorrágica argentina con una cepa atenuada de virus Junín: análisis de 636 vacunados. Pren. Méd. Argent. 1974, 61:231-240.
97. Rugiero H.A., Magnoni C., De Guerrero L.B., Milani H.A., Izquierdo F.P., Milani H.L., Weber E.L. Immunogenicity of A/USSR (H1N1) subunit vaccine in unprimed young adults (Persistence of antibodies and clinical evaluation in volunteers 7 to 9 years following the vaccination against Argentine hemorrhagic fever). J. Med. Virol. 1981, 7:227-232.
98. Rugiero H.R., Astarloa L., Gonzalez Cambaceres C., Maglio F., Squassi G. Immunization against Argentina hemorrhagic fever using a strain attenuated Junin virus. II. Immunization of volunteers, clinical and laboratory analysis. Medicina (B. Aires) 1969, 29:81-87.
99. Rugiero H.R., Greenway D.J., Parodi A.S., Lomban F.R., Frigerio M.J., Precerutti A.C., Boxaca M. Inoculación voluntaria del virus de la fiebre hemorrágica epidémica. Día Méd. 1959, 31:218-224.
100. Rugiero H.R., Greenway D.J., Parodi A.S., Rivero E., Frigerio M., Mettler N.E., Boxaca M., Nota N., de Guerrero L., Garzon F. Fiebre hemorragica epidemica; sintesis clinico-evolutiva. Dia Med. 1959, 31:236-243.
101. Sabattini M.S., Gonzales L.E. Identificación directa de virus Junin en roedores silvestres infectados en la naturaleza. Rev. Soc. Argent. Biol. 1967, 43:252-260.
102. Sabattini M.S., Gonzales L.E., Crespo J.A. Aislamiento de virus Junin en roedores silvestres de la Provincia de Cordoba. Seg. Jorn. Entomoepidemiol. Arg. 1967, 3:365-373.
103. Sabattini M.S., Gonzales De Rios L.E., Diaz G., Vega V.R. Infección natural y experimental de roedores con virus Junin. Medicina (B. Aires) 1977, 37(Suppl. 3):(149-161).
104. Sabattini M.S., Maiztegui J.I. Fiebre hemorrágica Argentina. Medicina (B. Aires) 1970, 30(Suppl. 1):111-128.
105. Samoilovich S.R., Calello M.A., Laguens R.P., Weissenbacher M.C. Long-term protection against Argentine hemorrhagic fever in Tacaribe virus infected marmosets: virologic and histopathologic findings. J. Med. Virol. 1988, 24:229-236.
106. Samoilovich S.R., Pecci Saavedra J., Frigerio M.J., Weissenbacher M.C. Nasal and intrathalamic inoculations of primates with Tacaribe virus: protection against Argentine hemorrhagic fever and absence of neurovirulence. Acta Virol. 1984, 28:277-281.
107. Sanchez A., Pifat D.Y., Kenyon R.H., Peters C.J., Mccormick J.B., Kiley M.P. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J. Gen. Virol. 1989, 70:1125-1132.
108. Spiropoulou C.F., Kunz S., Rollin P.E., Cambell K.P., Oldstone M.B.A. New World arenavirus Clade C, but not Clade A and B viruses, utilizes α-dystroglycan as its major receptor. J. Virol. 2002, 76:5140-5146.
109. Tauraso N., Shelokov A. Protection against Junin virus by immunization with live Tacaribe virus. Proc. Soc. Exp. Biol. Med. 1965, 119:608-611.
110. Videla C., Carballal G., Remorini P., La Torre J. Formalin inactivated Junin virus: immunogenicity and protection assays. J. Med. Virol. 1989, 29:215-220.
111. Vitullo A.D., Hodara V.L., Merani M.S. Effect of persistent infection with Junin virus on growth and reproduction of its natural reservoir, Calomys musculinus. Am. J. Trop. Med. Hyg. 1987, 37:663-669.
112. Vitullo A.D., Merani M.S. Is vertical transmission sufficient to maintain Junin virus in nature?. J. Gen. Virol. 1988, 69:1437-1440.
113. Vitullo A.D., Merani M.S. Vertical transmission of Junin virus in experimentally infected adult Calomys musculinus. Intervirology 1990, 31:339-344.
114. Weissenbacher M., De Guerrero L.B., Help G., Parodi A.S. Immunization against Argentina hemorrhagic fever using a strain of attenuated Junin virus. 3. Serological reactions in volunteers. Medicina (B. Aires) 1969, 29:88-92.
115. Weissenbacher M.C., Calello M.A., Colillas O.J., Rondinone S.N., Frigerio M.M. Argentine hemorrhagic fever: a primate model. Intervirology 1979, 11:363-365.
116. Weissenbacher M.C., Coto C.E., Calello M.A. Cross-protection between Tacaribe complex viruses. Presence of neutralizing antibodies against Junin virus (Argentine hemorrhagic fever) in guinea pigs infected with Tacaribe virus. Intervirology 1975, 6:42-49.
117. Weissenbacher M.C., Coto C.E., Calello M.A., Rondinone S.N., Damonte E.B., Frigerio M.J. Cross-protection in nonhuman primates against Argentine hemorrhagic fever. Infect. Immun. 1982, 35:425-430.
118. Weissenbacher M.C., Damonte E.B. Fiebre hemorrágica argentina. Adel. Microbiol. Enferm. Infecc. 1983, 2:119-171.
119. Weissenbacher M.C., Guerrero L.B., Boxaca M.C. Experimental biology and pathogenesis of Junin virus infection in animals and man. Bull. World Health Organ. 1975, 52:507-515.
120. Weissenbacher M.C., Laguens R.P., Coto C.E. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 1987, 134:79-116.
121. York J., Romanowski V., Lu M., Nunberg J.H. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J. Virol. 2004, 78:10783-10792.